TraceLink Leads Drug Supply Chain Security Act (DSCSA) and Serialization Compliance Discussion at Pharmaceutical Traceability Forum

NORTH READING, MA--(Marketwired - Mar 25, 2015) - TraceLink Inc., the leader in protecting patient safety and enabling health for global Life Sciences, announced today that Brian Daleiden, TraceLink's Vice President of Industry Marketing, will speak on the US Drug Supply Chain Security Act (DSCSA) and serialization preparedness at the Pharmaceutical Traceability Forum taking place March 30 - April 1, 2015 in Boston, Massachusetts. Attendees can also visit TraceLink in booth #1.

Global track and trace regulations incorporating the serialization, traceability and verification of pharmaceuticals will impact over 75 percent of the global drug supply by the end of 2018. Serialization and traceability readiness is now a strategic business requirement touching the entire organization and external supply network.

For organizations just starting down the serialization path, it is crucial to have a clear understanding of the underlying core issues and key trends that drive track and trace decision-making processes for pharmaceutical companies, their external supply network and their distribution trade ecosystem. The reality is that time is short to get started.

In his session entitled "Preparing for US DSCSA Serialization Deployment Using Key Learnings from Global Serialization and Trace and Trace Commercial Programs", conference participants will hear Mr. Daleiden provide a detailed overview of:

• The diversity of serialization requirements to consider and questions to ask
• How multi-national track and trace regulations impact US serialization planning
• Key learnings from global serialization implementations that inform business and IT decisions
• The crucial operational, supply chain and IT issues that companies need to consider in crafting a US serialization program
• A model for putting together a realistic US DSCSA serialization deployment timeline for your company

TraceLink's TraceLink Life Sciences Cloud, global track and trace applications and interconnected network of over 124,000 supply network entities are trusted by fifteen of the top 20 global pharmaceutical companies and businesses across the global supply chain from pharma manufacturer to pharmacy dispenser to meet serialization, traceability, reporting and other track and trace compliance requirements.

To learn more about meeting global pharmaceutical compliance deadlines designed to combat drug counterfeiting, and how to build a flexible global serialization, track and trace, and reporting platform for the US, European Union, Brazil, China and other countries, visit www.tracelink.com.

About TraceLink
TraceLink protects patients, enables health and ensures compliance for companies across the global Life Sciences supply network, including fifteen of the top-20 global pharmaceutical companies. Leading businesses trust the TraceLink Life Sciences Cloud, our Amazon AWS-based cloud application platform, to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn.

TraceLink is funded by FirstMark Capital, Volition Capital and Fidelity Biosciences.